(19)
(11) EP 3 110 420 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.07.2019 Bulletin 2019/28

(45) Mention of the grant of the patent:
13.02.2019 Bulletin 2019/07

(21) Application number: 15755054.2

(22) Date of filing: 25.02.2015
(51) International Patent Classification (IPC): 
A61K 31/42(2006.01)
C07D 413/14(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/US2015/017533
(87) International publication number:
WO 2015/130790 (03.09.2015 Gazette 2015/35)

(54)

SALTS OF HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE

SALZE VON HETEROCYCLISCHEN MODULATOREN DER HIF-AKTIVITÄT ZUR BEHANDLUNG VON KRANKHEITEN

SELS DE MODULATEURS HÉTÉROCYCLIQUES DE L'ACTIVITÉ DE HIF POUR LE TRAITEMENT DE MALADIES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 25.02.2014 US 201461944345 P

(43) Date of publication of application:
04.01.2017 Bulletin 2017/01

(73) Proprietor: Board of Regents, The University of Texas System
Austin, TX 78701 (US)

(72) Inventors:
  • JONES, Philip
    Houston, TX 77005 (US)
  • DI FRANCESCO, Maria, Emilia
    Houston, TX 77005 (US)
  • MCAFOOS, Timothy
    Houston, TX 77018 (US)

(74) Representative: Boult Wade Tennant LLP 
5th Floor, Salisbury Square House 8, Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)


(56) References cited: : 
WO-A1-2010/054763
WO-A2-2014/031936
US-A1- 2007 105 900
US-B1- 6 300 344
 WO-A2-2014/031936
US-A1- 2006 269 942
US-A1- 2011 301 122
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).